Amrize (NYSE:AMRZ) Sees Unusually-High Trading Volume – Time to Buy?

Amrize Ltd (NYSE:AMRZGet Free Report) saw unusually-strong trading volume on Monday . Approximately 8,061,620 shares traded hands during trading, an increase of 119% from the previous session’s volume of 3,680,764 shares.The stock last traded at $48.68 and had previously closed at $48.15.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Stephens assumed coverage on Amrize in a research report on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective for the company. Wells Fargo & Company increased their target price on Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Oppenheimer assumed coverage on Amrize in a research report on Tuesday, September 9th. They set an “outperform” rating and a $62.00 target price on the stock. Barclays initiated coverage on shares of Amrize in a research report on Tuesday, October 7th. They set an “equal weight” rating on the stock. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amrize in a report on Thursday, October 30th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $58.88.

Read Our Latest Stock Report on AMRZ

Amrize Trading Up 2.0%

The company has a market capitalization of $27.16 billion and a P/E ratio of 26.69. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The company’s 50 day simple moving average is $49.43.

Amrize (NYSE:AMRZGet Free Report) last posted its earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The firm’s revenue was up 6.6% on a year-over-year basis.

Insider Buying and Selling

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The shares were purchased at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares in the company, valued at $234,711.72. This trade represents a 67.61% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jaime Hill purchased 4,000 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were bought at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the transaction, the insider directly owned 18,101 shares in the company, valued at $917,539.69. This represents a 28.37% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 67,000 shares of company stock valued at $3,503,480 over the last three months.

Institutional Trading of Amrize

Large investors have recently added to or reduced their stakes in the business. State of Wyoming bought a new stake in Amrize during the third quarter worth approximately $32,000. US Bancorp DE bought a new stake in shares of Amrize during the 3rd quarter valued at $38,000. Costello Asset Management INC acquired a new stake in Amrize in the third quarter worth $44,000. Global Retirement Partners LLC acquired a new position in shares of Amrize in the third quarter valued at approximately $48,000. Finally, Jones Financial Companies Lllp bought a new stake in shares of Amrize in the third quarter worth $53,000.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.